Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-22

Clinical Trial Update: Repetitive Levosimendan Infusion for Patients With Advanced Chronic Heart Failure [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on repetitive levosimendan infusion for patients with advanced chronic heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levosimendan (levosimendan)

Snippet

Sponsor: Dr. Gerhard Pölzl | Conditions: Heart Failure | Phase 3 | Status: UNKNOWN